Zalicus discovers and develops treatments for pain and immuno-inflammatory diseases. Our pipeline includes Exalgo™ for moderate to severe pain, Synavive^®, for rheumatoid arthritis, Z160, an N-type calcium channel blocker for chronic inflammatory and neuropathic pain and Z944, a T-type calcium channel blocker for acute and inflammatory pain. Learn More

Zalicus discovers and develops innovative therapeutics for patients in need. We believe that our novel product candidates, productive drug discovery platforms, drug development expertise, revenue-generating collaborations and financial resources provide a solid foundation for success. Learn More